Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G/A for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT).
- Disclosed ownership: 0.4%.
- Date of event: 31 Dec 2025.
Deep Track Capital, LP - 31 Dec 2025 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- RAPT
- Disclosed Ownership
- 110,448 shares
- Ownership
- 0.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 08:51:46 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 0.4% ownership in RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2026, 08:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 0.4% | 110,448 | 0 | 110,448 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 0.4% | 110,448 | 0 | 110,448 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 0.4% | 110,448 | 0 | 110,448 | /s/ David Kroin | David Kroin |